Pediatrix Medical Group Financial Statements
NYSE: MDHealth CareHospital/Nursing ManagementUSD
Market open · Delayed 15 min · as of Oct 9, 12:29 PM ET
Pediatrix Medical Group revenue and earnings
In fiscal 2025, Pediatrix Medical Group generated $1.91 billion in revenue, down 4.9% from fiscal 2024, its first annual decline since 2020. Net income was $165.4 million, for a net margin of 8.6% versus a median of -3.0% in the prior 5 years. Operating margin was 10.9%.
Diluted earnings per share came in at $1.94. Over the last 5 fiscal years, MD's revenue has grown at a 2.0% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Pediatrix Medical Group income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.91B | 2.01B | 1.99B | 1.97B | 1.91B | 1.73B | 1.78B | 1.72B | 3.25B | 3.18B |
| Revenue growth (YoY) | -4.92% | +0.92% | +1.15% | +3.18% | +10.22% | -2.57% | +3.29% | -47.04% | +2.21% | +14.50% |
| Operating Expenses | 1.71B | 2.08B | 1.99B | 1.80B | 1.71B | 1.64B | 1.61B | 1.47B | 2.80B | 2.61B |
| Operating Income | 208.81M | -68.71M | 7.32M | 172.69M | 202.92M | 98.13M | 171.76M | 248.39M | 454.89M | 571.69M |
| Interest Expense | 35.97M | 40.74M | 42.08M | 39.70M | 68.72M | 110.48M | 118.93M | 92.94M | 74.56M | 63.09M |
| Other Income (Expense) | 7.62M | -32.63M | -55.68M | -91.32M | -67.69M | -90.98M | -112.97M | -82.18M | -69.22M | -57.89M |
| Pretax Income | 216.43M | -101.34M | -48.36M | 81.37M | 135.23M | 7.15M | 58.78M | 166.21M | 385.67M | 513.80M |
| Income Tax | 51.04M | -2.27M | 12.05M | 18.81M | 27.24M | 16.73M | 16.58M | 44.69M | 80.23M | 189.20M |
| Net Income | 165.39M | -99.07M | -60.41M | 66.33M | 130.96M | -796.49M | -1.50B | 268.63M | 320.37M | 324.91M |
| Net Income growth (YoY) | — | — | -191.07% | -49.35% | — | — | -657.54% | -16.15% | -1.40% | -3.39% |
| EPS (Basic) | 1.97 | -1.19 | -0.73 | 0.79 | 1.54 | -9.55 | -17.94 | 2.95 | 3.47 | 3.52 |
| EPS (Diluted) | 1.94 | -1.19 | -0.73 | 0.79 | 1.53 | -9.55 | -17.83 | 2.93 | 3.45 | 3.49 |
| Shares Outstanding (Basic) | 84.44M | 83.33M | 82.20M | 83.47M | 84.83M | 83.39M | 83.50M | 91.10M | 92.43M | 92.42M |
| Shares Outstanding (Diluted) | 85.43M | 83.33M | 82.20M | 84.12M | 85.83M | 83.39M | 84.01M | 91.61M | 92.96M | 93.11M |
| EBITDA | 230.64M | -36.49M | 43.49M | 208.32M | 235.06M | 126.57M | 197.69M | 272.74M | 533.75M | 660.95M |
| Operating Margin | 10.91% | -3.41% | 37.00% | 8.76% | 10.62% | 5.66% | 9.65% | 14.42% | 13.98% | 17.96% |
| Net Margin | 8.64% | -4.92% | -3.03% | 3.36% | 6.85% | -45.93% | -84.15% | 15.59% | 9.85% | 10.21% |
This table shows 10 annual periods of Pediatrix Medical Group's income statement, from FY 2025 back to FY 2016, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow MD's reporting calendar. What is a income statement?